Skip to Main Content

Author Details

Sara L Van Driest
National Institutes of Health
2002
128
30
PMIDPaper TitleJournal TitlePublished Year
38041473Developing and evaluating pediatric phecodes (Peds-Phecodes) for high-throughput phenotyping using electronic health records.J Am Med Inform Assoc2024
36350309Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.Clin Transl Sci2023
37662324Clinical consequences of a polygenic predisposition to benign lower white blood cell counts: Consequences of benign WBC count genetics.medRxiv2023
37662278Developing and Evaluating Pediatric Phecodes (Peds-Phecodes) for High-Throughput Phenotyping Using Electronic Health Records.medRxiv2023
37704356Current Practices in Pharmacogenomics.Pediatr Clin North Am2023
37651384Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection.PLoS One2023
37930895Next-generation phenotyping: introducing phecodeX for enhanced discovery research in medical phenomics.Bioinformatics2023
35679217Direct-to-patient telehealth equity: Reaching diverse pediatric populations in primary care.Fam Syst Health2023
35393523Bronchopulmonary dysplasia is associated with polyhydramnios in a scan for novel perinatal risk factors.Pediatr Res2023
37353859Variant-based heritability assessment of dexmedetomidine and fentanyl clearance in pediatric patients.Clin Transl Sci2023
37164130Pediatric Persistent Inflammation, Immunosuppression, and Catabolism Syndrome Prevalence in Sepsis-Related Mortalities: A 23-Year Institutional History.Chest2023
36919492A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens.Expert Opin Drug Metab Toxicol2023
36524442Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support.Pharmacotherapy2023
36366911Tutorial: Using Community Engagement Studios to Enhance Pharmacogenetic Study Design for Maximizing Enrollment of Diverse Children and Pregnant People.Clin Pharmacol Ther2023
35895516White blood cell ranges and frequency of neutropenia by Duffy genotype status.Blood Adv2023
34562070Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.Clin Transl Sci2022
35642720Frequency of benign neutropenia among Black versus White individuals undergoing a bone marrow assessment.J Cell Mol Med2022
35724382Race, Genotype, and Azathioprine Discontinuation : A Cohort Study.Ann Intern Med2022
35568931Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.Implement Sci Commun2022
35389944Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients.Pharmacogenet Genomics2022
35514162Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population.Clin Transl Sci2022
35988586Association between nitric oxide synthase 3 genetic variant and acute kidney injury following pediatric cardiac surgery.Am Heart J2022
36124058Medication history-wide association studies for pharmacovigilance of pregnant patients.Commun Med (Lond)2022
33824446Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.Pediatr Res2022
33755393An Integrated Clinical and Genetic Prediction Model for Tacrolimus Levels in Pediatric Solid Organ Transplant Recipients.Transplantation2022
35216901The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network.Genet Med2022
34877660Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population.Clin Pharmacol Ther2022
34997625Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real-world data and simulated data.Br J Clin Pharmacol2022
35058154Molecular characterization and investigation of the role of genetic variation in phenotypic variability and response to treatment in a large pediatric Marfan syndrome cohort.Genet Med2022
35199555Diastolic Blood Pressure Alleles Improve Congenital Heart Defect Repair Outcomes.Circ Res2022
34930020Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.Circulation2022
34986912Impact of obesity on post-operative arrhythmias after congenital heart surgery in children and young adults.Cardiol Young2022
34957589Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens.Br J Clin Pharmacol2022
32770672Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.Clin Pharmacol Ther2021
33759847Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics.J Dev Behav Pediatr2021
34412159Progress and Challenges in Pharmacogenomics.Clin Pharmacol Ther2021
34390503Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw.Clin Pharmacol Ther2021
34834403Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program.J Pers Med2021
34043820Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics.Clin Pharmacol Ther2021
34101169Moving Pharmacogenetics Into Practice: It's All About the Evidence!Clin Pharmacol Ther2021
34180972Association Between a Common, Benign Genotype and Unnecessary Bone Marrow Biopsies Among African American Patients.JAMA Intern Med2021
34151428Genome-Wide Approach to Measure Variant-Based Heritability of Drug Outcome Phenotypes.Clin Pharmacol Ther2021
34032507The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents.Pharmacogenomics2021
34282303Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.Genet Med2021
33428770Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Clin Pharmacol Ther2021
33048353A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT.Clin Pharmacol Ther2021
33446915Research consent rates before and during a COVID-19 one-visitor policy in a children's hospital.Pediatr Res2021
33325650Characterizing Pharmacogenetic Testing Among Children's Hospitals.Clin Transl Sci2021
33387367Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.Clin Pharmacol Ther2021
32860906Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.J Am Acad Child Adolesc Psychiatry2021
  • 1 - 50 of 128

Recommended Authors

Nicholas P Giangreco
Columbia University
Career Start Year 2017
Number of shared co-authors 0
Gillian C Bell
Mission Health Personalized Medicine & Pharmacogenomics Program
Career Start Year 2011
Number of shared co-authors 28
Robert L Davis
Center for Biomedical Informatics, University of Tennessee Health Science Center
Career Start Year 2011
Number of shared co-authors 16
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 79
Kandamurugu Manickam
Nationwide Children's Hospital, The Ohio State University College of Medicine
Career Start Year 2010
Number of shared co-authors 30
Daniel S Herman
University of Pennsylvania
Career Start Year 2009
Number of shared co-authors 18
Nicholas P Tatonetti
Columbia Universtiy College of Physicians and Surgeons
Career Start Year 2009
Number of shared co-authors 27
Jill Hardin
Janssen Pharmaceutical Research and Development
Career Start Year 2009
Number of shared co-authors 3
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 21
Nathan E Wineinger
Scripps Research Translational Institute, The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 0
Catherine A Brownstein
Harvard Medical School.
Career Start Year 2008
Number of shared co-authors 8
David Dimmock
Rady Children's Institute for Genomic Medicine
Career Start Year 2007
Number of shared co-authors 12
Ian B Stanaway
Kidney Research Institute and Division of Nephrology, University of Washington
Career Start Year 2006
Number of shared co-authors 79
Changchun Xie
University of Cincinnati
Career Start Year 2004
Number of shared co-authors 3
Alon Geva
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 3
Eileen King
Cincinnati Children's Hospital Medical Center
Career Start Year 2002
Number of shared co-authors 5
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 11
Shannon Haymond
Ann Robert H. Lurie Childrens Hospital of Chicago
Career Start Year 2000
Number of shared co-authors 0
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 8
Deepak Voora
Durham VA Healthcare System and Duke University
Career Start Year 1998
Number of shared co-authors 25
Ulrich Broeckel
Medical College of Wisconsin
Career Start Year 1998
Number of shared co-authors 42
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 8
Helena Kirchner
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 29
Shannon Manzi
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 55
Michelle Whirl-Carrillo
Stanford University
Career Start Year 1995
Number of shared co-authors 39
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 11
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 77
Karen E Weck
University of North Carolina at Chapel Hill
Career Start Year 1987
Number of shared co-authors 43
Geoffrey S Ginsburg
National Institutes of Health
Career Start Year 1981
Number of shared co-authors 38

Collaborators

Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 44
Joshua C Denny
Vanderbilt University
Co-authored papers 31
Jonathan D Mosley
Vanderbilt University Medical Center
Co-authored papers 25
Quinn S Wells
Vanderbilt University Medical Center
Co-authored papers 17
Christian M Shaffer
Vanderbilt University
Co-authored papers 14
Michael J Ackerman
Mayo Clinic, Windland Smith Rice Genetic Heart Rhythm Clinic)
Co-authored papers 14
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 13
Iftikhar J Kullo
Mayo Clinic
Co-authored papers 11
Lisa Bastarache
Vanderbilt University Medical Center
Co-authored papers 10
Erica Bowton
Institute for Clinical and Translational Research, Vanderbilt University
Co-authored papers 10
Wei-Qi Wei
Vanderbilt University Medical Center
Co-authored papers 10
Tracy L McGregor
Alnylam Pharmaceuticals
Co-authored papers 10
Todd L Edwards
Vanderbilt University Medical Center
Co-authored papers 10
Steve R Ommen
Mayo Clinic
Co-authored papers 10
Gail P Jarvik
University of Washington Medical Center
Co-authored papers 10
Peter Weeke
Rigshospitalet, University of Copenhagen
Co-authored papers 9
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Co-authored papers 9
Eric B Larson
University of Washington
Co-authored papers 8
Jason H Karnes
Vanderbilt University Medical Center
Co-authored papers 8
Andrew H Smith
The Heart Institute, Johns Hopkins All Children's Hospital
Co-authored papers 8
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 8
Jonathan S Schildcrout
Vanderbilt University Medical Center.
Co-authored papers 7
Marc S Williams
University of Washington Medical Center
Co-authored papers 7
Robert J Carroll
Vanderbilt University Medical Center
Co-authored papers 6
David R Crosslin
University of Washington Medical Center
Co-authored papers 6
Charles M Stein
Vanderbilt University School of Medicine
Co-authored papers 6
James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 6
Murray H Brilliant
Marshfield Clinic Research Institute
Co-authored papers 6
Jill M Pulley
Vanderbilt University School of Medicine
Co-authored papers 5
E Clayton
Harvard Medical School, Vanderbilt University, Yale University Yale Law School
Co-authored papers 5
Release 1.2